Indeed, analysis of OS tumor databases reveals that high intra-tumoral expression of CXCL10 and/or CXCR3 correlates with improved prognosis, consistent with a robust local anti-tumor immune response [22,29,30,31,32]. Here, CXCL10 is linked to neoplasm.